Darling Ingredients (DAR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 Mar, 2026Executive summary
Annual meeting scheduled for May 7, 2026, with virtual attendance available for shareholders.
Shareholders are invited to vote on key proposals, including director elections, auditor ratification, executive compensation, and an incentive plan.
Voting matters and shareholder proposals
Election of ten director nominees to serve until the next annual meeting.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending January 2, 2027.
Advisory vote to approve executive compensation.
Approval of the 2026 Omnibus Incentive Plan.
Other business may be addressed as permitted by company bylaws.
Board of directors and corporate governance
Ten nominees listed for election to the board, with board recommending a vote for each.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Darling Ingredients
- Q2 2026 delivered record net income, EBITDA, and debt reduction on strong segment results.DAR
Q2 2026 - All director nominees, auditor ratification, and key compensation plans were approved.DAR
AGM 2026 - Accelerated growth, strong cash flow, and innovation in collagen set the stage for robust expansion.DAR
21st Annual Global Farm to Market Conference - Global scale, strong cash flow, and innovation in renewables and collagen drive profitable growth.DAR
Investor Day 2026 - Net income hit $134.3 million and Adjusted EBITDA more than doubled year-over-year.DAR
Q1 2026 - Shareholders will vote on directors, auditor, executive pay, and a new incentive plan amid strong 2025 results.DAR
Proxy filing - Q4/FY2025 sales and margins rose, but net income fell sharply on restructuring charges.DAR
Q4 2025 - Feed and Food drove margin gains, but Fuel/DGD losses and policy risks weighed on results.DAR
Q3 2025 - Q3 2024 net income fell to $16.9M; 2024 EBITDA guidance is $1.15–$1.175B, 2025 to exceed $1.5B.DAR
Q3 2024